BMYMP
Bristol-Myers Squibb Company PFD CONV 2
OTCHealthcareDrug Manufacturers - GeneralUS
Company Profile
CEO
Christopher S. Boerner
IPO Date
2003-12-08
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC
Country
US
Bristol-Myers Squibb Company PFD CONV 2
CEO
Christopher S. Boerner
IPO Date
2003-12-08
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC
Country
US
| 657.767 |
| $0.00 |
| 3 Jan 2024 | Storch Gerald L | director | A-Award | Acquired | 706.49 | $0.00 |
| 3 Jan 2024 | Rice Derica W | director | A-Award | Acquired | 706.49 | $0.00 |
| 3 Jan 2024 | Haller Julia A | director | A-Award | Acquired | 706.49 | $0.00 |
| 3 Jan 2024 | YALE PHYLLIS R | director | A-Award | Acquired | 657.767 | $0.00 |
| 7 Dec 2023 | BOERNER CHRISTOPHER S. | Chief Executive Officer | P-Purchase | Acquired | 2,000 | $49.78 |
| 5 Dec 2023 | Plenge Robert M | EVP, Chief Research Officer | M-Exempt | Acquired | 616 | $0.00 |
| 5 Dec 2023 | Plenge Robert M | EVP, Chief Research Officer | F-InKind | Disposed | 274 | $50.10 |
| 5 Dec 2023 | Plenge Robert M | EVP, Chief Research Officer | M-Exempt | Disposed | 616 | $0.00 |